2-Year Patent Extension For Levaquin Sticks
A federal judge has upheld a two-year extension for Japanese drugmaker Daiichi Pharmaceutical Co.'s Levaquin patent, rejecting an effort by Lupin Ltd. to launch a generic version of the anti-bacterial blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article